Modifiable Risk Factors for Delayed Graft Function After Deceased Donor Kidney Transplantation

Prog Transplant. 2019 Sep;29(3):269-274. doi: 10.1177/1526924819855357. Epub 2019 Jun 5.

Abstract

Purpose: Delayed graft function is a major complication after kidney transplantation affecting patients' long-term outcome. The aim of this study was to identify modifiable risk factors for delayed graft function after deceased donor kidney transplantation.

Methods: This is a single-center retrospective cohort study of a university transplantation center. Univariate and multivariate step-wise logistic regression analysis of patient-specific and procedural risk factors were conducted.

Results: We analyzed 380 deceased donor kidney transplantation patients between October 30, 2008 and December 30, 2017. The incidence of delayed graft function was 15% (58/380). Among the patient-specific risk factors recipient diabetes (2.8 [1.4-5.9] odds ratio [OR] [95% confidence interval [CI]]), American Society of Anesthesiologist score of 4 (2.7 [1.2-6.5] OR [95% CI]), cold ischemic time >13 hours (2.8 [1.5-5.3] OR [95% CI]) and donor age >55 years (1.9 [1.01-3.6] OR [95% CI]) revealed significance. The significant intraoperative, procedural risk factors included the use of colloids (3.9 [1.4-11.3] OR [95% CI]), albumin (3.0 [1.2-7.5] OR [95% CI]), crystalloids >3000 mL (3.1 [1.2-7.5] OR [95% CI]) and mean arterial pressure <80 mm Hg at the time of reperfusion (2.4 [1.2-4.8] OR [95% CI]).

Conclusion: Patients undergoing deceased donor kidney transplantation with a mean arterial pressure >80 mm Hg at the time of transplant reperfusion without requiring excessive fluid therapy in terms of colloids, albumin or crystalloids >3000 mL are less likely to develop delayed graft function.

Keywords: delayed graft function; fluid therapy; intraoperative hemodynamic management; kidney transplantation; risk factors.

MeSH terms

  • Albumins / therapeutic use
  • Arterial Pressure
  • Cohort Studies
  • Cold Ischemia / statistics & numerical data
  • Colloids / therapeutic use
  • Crystalloid Solutions / therapeutic use
  • Delayed Graft Function / epidemiology*
  • Female
  • Fluid Therapy / statistics & numerical data*
  • Humans
  • Incidence
  • Kidney Failure, Chronic / surgery*
  • Kidney Transplantation*
  • Logistic Models
  • Male
  • Multivariate Analysis
  • Odds Ratio
  • Retrospective Studies
  • Risk Factors
  • Tissue Donors / statistics & numerical data*

Substances

  • Albumins
  • Colloids
  • Crystalloid Solutions